Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$539,427
-$2,696,215 QoQ
Shares Held
39,928
-84.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Sep 30, 2022CallValue
$231,744
CallShares
27,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Verition Fund Management LLC holds $14,533,555 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
211,287 | $5,056,097 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
60,000 | $4,551,000 | |
| 3 | LQDA |
Liquidia Corp
|
60,111 | $2,268,589 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
29,919 | $676,169 | |
| 5 | VTRS |
Viatris Inc
This page
|
39,928 | $539,427 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
13,362 | $402,463 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
18,597 | $364,315 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
10,604 | $350,674 |
All Filings in VTRS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $539,427 | 39,928 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,235,642 | 259,891 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,488,890 | 150,393 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,702,744 | 302,659 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,702,883 | 195,509 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,880,705 | 231,382 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $258,775 | 22,289 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $244,436 | 22,995 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $482,017 | 40,370 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $120,830 | 11,157 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $209,613 | 21,259 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $242,723 | 24,321 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $876,891 | 91,153 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $297,015 | 26,686 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $386,994 | 45,422 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $231,744 | 27,200 | Call | Other | 2023-01-18 | |
| 2022-06-30 | $312,068 | 29,806 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $546,176 | 50,200 | Call | Other | 2022-06-02 | |
| 2021-06-30 | $478,457 | 33,482 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $698,500 | 50,000 | Call | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||